Tim-3 adaptor protein Bat3 is a molecular checkpoint of T cell terminal differentiation and exhaustion
Open accessThe DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
Tim-3 adaptor protein Bat3 regulates T cell terminal differentiation and exhaustion in an mTORC2-dependent manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Tim-3 signaling partially contributes to Bat3-mediated T cell exhaustion. (A) CD4 T cells from Bat3cko × 2D2 and WT 2D2 mice were in vitro differentiated into TH1 cells, and 4 × 106 cells were transferred into C57BL/6 recipient mice to induce EAE. Disease progression was monitored on daily basis until the end of the experiment. Mean disease scores are shown as indicated. (B to E) Ex vivo analyses on transferred 2D2 cells (Va3.2+Vb11+) in the central nervous system (CNS), spleen (SPN), and lymph node (LN) on day 12 (D12) and day 21 (D21) were performed to determine the phenotype of Bat3-deficient CD4 T cells during EAE induction. Error bars indicate mean SEM [*P = 0.01, **P = 0.0085, and ***P = 0.006, unpaired two-tailed t test; ****P = 0.0001, two-way analysis of variance (ANOVA)]. NS, not significant. (F) Naïve CD4 T cells were isolated from Bat3fl/fl, Tim-3cko, Bat3cko × 2D2, and Tim-3×Bat3dko × 2D2 mice and were in vitro differentiated into TH1 cells; 4 × 106 cells were transferred into C57BL/6 recipient mice to induce EAE. Disease progression was monitored on daily basis till the end of experiment. Mean disease scores were shown as indicated. Statistical significance between Tim-3cko × 2D2 and Tim-3×Bat3dko × 2D2 was reached on D12 (**), increasing in significance until cessation of experiment. Statistical significance between Bat3cko × 2D2 and Tim-3 × Bat3dko × 2D2 mice was reached on D8 (*), increasing in significance until cessation of experiment. (G) Ex vivo analyses on transferred 2D2 cells (Va3.2+Vb11+) in the CNS on D21 was performed to determine the phenotype of Bat3fl/fl, Tim-3cko, Bat3cko × 2D2, and Tim-3 × Bat3dko–deficient CD4 T cells during EAE induction. Data represent three independent experiments. Error bars indicate mean SEM (*P = 0.01 and ***P = 0.0012, unpaired two-tailed t test; ****P = 0.0001, two-way ANOVA).](https://figures.cochat.ai/paper-figures/e26f9bf32d03420582098495f3b7ba04/tim-3-adaptor-protein-bat3-is-a-molecular-checkpoint-of-t-cell-terminal-figure-1.jpg)







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Release of BAT3 suggests that FYN tyrosine‐protein kinase links with the TIM‐3 cytoplasmic tail to generate inhibitory signaling that causes anergy of T cells by activating the transmembrane protein phosphoprotein membrane anchor with glycosphingolipid microdomains 1 (PAG1). This prompts the recruitment of tyrosine kinase (CSK), leading to phosphorylating LCK and suppressing T cells [308, 312].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [312]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665 · cited 1×
“As the interaction with Rictor is required for mTOR kinase activity, the regulation of Rictor binding to mTOR would be an important mechanism to control mTORC2 activity (22, 23).”
BackgroundProlonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072
Self-citationDefining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,472
Self-citationMolecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,354
Li, H., van der Leun, A. M., Yofe, I., Lubling, Y., Gelbard-Solodkin, D., van Akkooi, A. C. J., van den Braber, M., Rozeman, E. A., Haanen, J. B. A. G., Blank, C. U., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.043 · Cited by 1,101
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
Jin, H.-T., Anderson, A. C., Tan, W. G., West, E. E., Ha, S.-J., Araki, K., Freeman, G. J., Kuchroo, V. K., & Ahmed, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009731107 · Cited by 858
Self-citationImmunoregulatory functions of mTOR inhibition
Thomson, A. W., Turnquist, H. R., & Raimondi, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2546 · Cited by 847 · cited 3×
“The molecular mechanism by which mTORC1 is regulated has been extensively investigated, but knowledge of mTORC2 regulation is still limited (40).”
BackgroundInfluential
Cited by
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
Endoplasmic reticulum stress—a key guardian in cancer
Zhang, W., Shi, Y., Oyang, L., Cui, S., Li, S., Li, J., Liu, L., Li, Y., Peng, M., Tan, S., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02110-3 · Cited by 173
“A study had elucidated a potential mechanism by which DCs de fi cient in the adapter protein BAT3, which interacts with TIM-3 on T cells, exhibit a hyperactive UPR, leading to the development of a tolerogenic phenotype that subsequently attenuates the ef fi cacy of anti-tumor T cell responses [145].”
BackgroundDecoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity
Salvagno, C., Mandula, J. K., Rodríguez, P. C., & Cubillos‐Ruiz, J. R. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.06.006 · Cited by 144
Control of immune cell function by the unfolded protein response
Conza, G. D., Ho, P., Cubillos‐Ruiz, J. R., & Huang, S. C. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00838-0 · Cited by 116
İmani, S., Farghadani, R., Roozitalab, G., Maghsoudloo, M., Emadi, M., Moradi, A., Abedi, B., & Kaboli, P. J. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03394-8 · Cited by 131
Metadata
- Authors
- Zhu, C., Dixon, K. O., Newcomer, K., Gu, G., Xiao, S., Zaghouani, S., Schramm, M. A., Wang, C., Zhang, H., Goto, K., Christian, E., Rangachari, M., Rosenblatt-Rosen, O., Okada, H., Mak, T., Singer, M., Regev, A., & Kuchroo, V.
- Affiliations
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Harvard University (US)
- Celsius Therapeutics (United States) (US)
- University Health Network (CA)
- Department of Data Sciences, DFCI, Boston, MA 02215, USA.
- Université Laval (CA)
- Kindai University (JP)
- Corresponding author
- Zhu, Chen
- Dixon, Karen O.
- Kuchroo, Vijay
- ORCID
- Venue
- Science Advances
- Published
- 2021-04-30
- Volume
- 7
- Issue
- 18
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8087420
- OpenAlex
- W3159845336
- Cited by
- 40
- References
- 53
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 9 · 2023: 9 · 2022: 5
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- Japan Society for the Promotion of Science (21K07135)
- National Institute of Allergy and Infectious Diseases (P01AI073748, U19AI133524, P01AI056299)
- National Institute of Neurological Disorders and Stroke (R01NS030843, R29NS030843, P01NS038037, R37NS030843, R01NS045937)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- BAT3, TIM-3, T cell exhaustion, T cell dysfunction, autoimmune disease, effector function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tim-3 adaptor protein Bat3 is a molecular checkpoint of T cell terminal differentiation and exhaustion. https://app.cochat.ai/papers/10.1126/sciadv.abd2710
- The paper
- Zhu, C., Dixon, K. O., Newcomer, K., Gu, G., Xiao, S., Zaghouani, S., Schramm, M. A., Wang, C., Zhang, H., Goto, K., Christian, E., Rangachari, M., Rosenblatt-Rosen, O., Okada, H., Mak, T., Singer, M., Regev, A., & Kuchroo, V. (2021). Tim-3 adaptor protein Bat3 is a molecular checkpoint of T cell terminal differentiation and exhaustion. Science Advances. https://doi.org/10.1126/sciadv.abd2710
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.